Skip to main content
NCBI home page
Gut logoLink to Gut
. 1971 Jul;12(7):574–578. doi: 10.1136/gut.12.7.574

The serum concentration of the third component of complement β1C/β1A in liver disease

R A Fox, F J Dudley, Sheila Sherlock
PMCID: PMC1411859  PMID: 4997691

Abstract

Serum C3 (β1C/β1A) has been measured in normal individuals and the range found is in agreement with findings of other authors (85-370 mg/100 ml). In 18 patients with acute hepatitis and massive necrosis serum C3 was consistently reduced to below 50% of normal. In other patients with acute hepatitis the serum C3 concentration was normal. In the majority of the 150 patients with chronic liver disease serum C3 concentration was normal. However, 10 patients (six with active chronic hepatitis, four with cryptogenic cirrhosis) had hypocomplementaemia. The reason for the depression is not clear but could reflect either decreased synthesis or increased consumption, or a combination of the two.

Full text

PDF
574

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHERSON G. L. Serum complement levels in systemic lupus erythematosus and other diseases. Australas Ann Med. 1960 Feb;9:57–63. doi: 10.1111/imj.1960.9.1.57. [DOI] [PubMed] [Google Scholar]
  2. Almeida J. D., Waterson A. P. Immune complexes in hepatitis. Lancet. 1969 Nov 8;2(7628):983–986. doi: 10.1016/s0140-6736(69)90540-6. [DOI] [PubMed] [Google Scholar]
  3. Alper C. A., Johnson A. M., Birtch A. G., Moore F. D. Human C'3: evidence for the liver as the primary site of synthesis. Science. 1969 Jan 17;163(3864):286–288. doi: 10.1126/science.163.3864.286. [DOI] [PubMed] [Google Scholar]
  4. Alper C. A., Rosen F. S. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients. J Clin Invest. 1967 Dec;46(12):2021–2034. doi: 10.1172/JCI105691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GOLDGRABER M. B., KIRSNER J. B. The hypersensitive state and the liver: a critical review. Am J Med Sci. 1961 Jan;241:109–125. doi: 10.1097/00000441-196101000-00014. [DOI] [PubMed] [Google Scholar]
  6. KLEMPERER M. R., GOTOFF S. P., ALPER C. A., LEVIN A. S., ROSEN F. S. ESTIMATION OF THE SERUM BETA-1C GLOBULIN CONCENTRATION: ITS RELATION TO THE SERUM HEMOLYTIC COMPLEMENT TITER. Pediatrics. 1965 May;35:765–769. [PubMed] [Google Scholar]
  7. Knight A. H., Fox R. A., Baillod R. A., Niazi S. P., Sherlock S., Moorhead J. F. Hepatitis-associated antigen and antibody in haemodialysis patients and staff. Br Med J. 1970 Sep 12;3(5723):603–606. doi: 10.1136/bmj.3.5723.603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Mueller-Eckhardt C., Kretzschmar G., Kühn H. A. Untersuchungen zur Bedeutung des beta 1C-1A-Gehaltes im Serum von Patienten mit sog "lupoider" Hepatitis. Klin Wochenschr. 1970 Apr 15;48(8):491–493. doi: 10.1007/BF01485101. [DOI] [PubMed] [Google Scholar]
  9. Pickering R. J., Gewurz H., Good R. A. Complement inactivation by serum from patients with acute and hypocomplementemic chronic glomerulonephritis. J Lab Clin Med. 1968 Aug;72(2):298–307. [PubMed] [Google Scholar]
  10. Popper H., Paronetto F., Schaffner F. Immune processes in the pathogenesis of liver disease. Ann N Y Acad Sci. 1965 Jun 30;124(2):781–799. doi: 10.1111/j.1749-6632.1965.tb19001.x. [DOI] [PubMed] [Google Scholar]
  11. Townes A. S. Topics in clinical medicine. Complement levels in disease. Johns Hopkins Med J. 1967 May;120(5):337–343. [PubMed] [Google Scholar]
  12. WALKER J. G., DONIACH D., ROITT I. M., SHERLOCK S. SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS. Lancet. 1965 Apr 17;1(7390):827–831. doi: 10.1016/s0140-6736(65)91372-3. [DOI] [PubMed] [Google Scholar]
  13. WEST C. D., NORTHWAY J. D., DAVIS N. C. SERUM LEVELS OF BETA-1C GLOBULIN, A COMPLEMENT COMPONENT, IN THE NEPHRITIDES, LIPOID NEPHROSIS, AND OTHER CONDITIONS. J Clin Invest. 1964 Aug;43:1507–1517. doi: 10.1172/JCI105027. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES